Qianying Liao

Qianying Liao

Auto-generated profile, based on publicly available information

Qianying Liao

DistriNet, Department of Computer Science, KU Leuven, B-3001 Leuven, Belgium

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2023 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
JLJun-Ze Liang
Jun-Ze Liang
DLDe-Hua Li
De-Hua Li
YXYong-Chun Xiao
Yong-Chun Xiao
FSFu-Jin Shi
Fu-Jin Shi
TZTairan Zhong
Tairan Zhong
QHQing-Yu He
Qing-Yu He
Protein lysine acetylation is a critical post-translational modification involved in a wide range of biological processes. To date, about 20,000 acetylation sites of Homo sapiens were identified through mass spectrometry- based proteomic technology, but more than 95% of them have unclear functional annotations because of the lack of existing prioritization strategy to assess the functional importance of the acetylation sites on large scale. Hence, we established a lysine acetylation functional evaluating model (LAFEM) by considering eight critical features surrounding lysine acetylation site to high- throughput estimate the functional importance of given acetylation sites. This was achieved by selecting one of the random forest models with the best performance in 10-fold cross-validation on undersampled training data- set. The global analysis demonstrated that the molecular environment of acetylation sites with high acetylation functional scores (AFSs) mainly had the features of larger solvent-accessible surface area, stronger hydrogen bonding-donating abilities, near motif and domain, higher homology, and disordered degree. Importantly, LAFEM performed well in validation dataset and acetylome, showing good accuracy to screen out fi tness directly relevant acetylation sites and assisting to explain the core reason for the difference between biological models from the perspective of acetylome. We further used cellular experiments to confirm that, in nuclear casein kinase and cyclin-dependent kinase substrate 1, acetyl-K35 with higher AFS was more important than acetyl-K9 with lower AFS in the proliferation of A549 cells. LAFEM provides a prioritization strategy to large scale discover the fi tness directly relevant acetylation sites, which constitutes an unprecedented resource for better understanding of functional acetylome.

2 September 2021
Verified
Book Chapter
Closed access
PDF file
SWSihang Wu
Sihang Wu
CXCanyu Xie
Canyu Xie
YHYuhao Huang
Yuhao Huang
GTGuozhi Tang
Guozhi Tang
QLQianying Liao
Qianying Liao
LJLianwen Jin
Lianwen Jin

3 October 2025
Verified
Book Chapter
Closed access
QLQianying Liao
Qianying Liao
DPDavy Preuveneers
Davy Preuveneers
DLDimitri van Landuyt
Dimitri van Landuyt
WJWouter Joosen
Wouter Joosen
The trend to support healthcare outside of the premises and control of health institutions has given rise to a diversity of devices (e.g. wearables), services, and players contributing to the ecosystem. In consequence, health-related and medical data are frequently dispersed across multiple institutions and devices, posing a significant challenge to comprehensive data analysis and exploration for AI-driven research on new medicines or treatments. Centralizing such sensitive data is often unachievable due to the rigorous security and privacy demands imposed by various stakeholders, including patients, general practitioners, and pharmaceutical researchers. The decentralized and dispersed nature of healthcare data, in combination with stringent regulatory constraints such as HIPAA and GDPR, necessitate innovative approaches to collaborative healthcare research. Federated learning is a promising class of solutions to harness the collective intelligence of diverse datasets by allowing collaborative model training across decentralized data sources. Despite the many privacy-enhancing techniques proposed to ensure the confidentiality of data and intellectual property, this chapter discusses and illustrates the challenges of leveraging shared representations and knowledge transfer between smart health applications while addressing the intricacies of data fragmentation, security, and privacy.

23 October 2026
Verified
Book Chapter
Closed access
PDF file
JVJenno Verdonck
Jenno Verdonck
QLQianying Liao
Qianying Liao
MWMichiel Willocx
Michiel Willocx
WJWouter Joosen
Wouter Joosen
VNVincent Naessens
Vincent Naessens
DLDimitri Van Landuyt
Dimitri Van Landuyt

3 June 2025
Verified
Preprint
Open access
QLQianying Liao
Qianying Liao
DLDimitri Van Landuyt
Dimitri Van Landuyt
WJWouter Joosen
Wouter Joosen
Many of the technological advances we witness today are based on novel and innovative ways to derive value from data sets. However, these data sets are often comprised of personal or confidential data records which prohibits or complicates their direct use. In the complex contemporary data processing pipelines that drive many applications, synthetic data sets can be used as surrogate replacements of original data, and this --at least at face value-- alleviates these concerns. However, evaluating the privacy and confidentiality of synthetic data is not straightforward. While much attention is spent on metrics and quantification approaches, a broader threat model-oriented perspective is lacking. In this literature review article, we provide overview of the different approaches, metrics, assumptions and attacker models used in academic research to evaluate the privacy of tabular synthetic data. This study shows that scientific privacy evaluations in this domain is increasingly diverse and diverging, with different studies adopting different privacy threat models, under different attacker assumptions and different privacy metrics --- both non-adversarial and adversarial. Based on our findings, we argue in favor of more harmonized and concerted efforts within the broader research domain, to promote more complete and empirically sound benchmarks and evaluations of privacy risks in the use of synthetic data.